Market Strategy
Articles
News
Daily Comment
Visie Van De Week
Real-time charts
Contact
About us
Links
Market Strategy
Articles
News
Daily Comment
Visie Van De Week
Real-time charts
Contact
About us
Links
Market Strategy
Articles
News
Daily Comment
Visie Van De Week
Real-time charts
Market Strategy
Articles
News
Daily Comment
Visie Van De Week
Real-time charts
About us
Contact
Links
About us
Contact
Links
Accordion Title
Accordion Content
more items +
Stocks tend to suffer in the second half of September — but the Fed’s rate cut might keep bears at bay
People are complaining that Apple’s new iPhone 17 scratches easily — but these Wall Street analysts say it won’t hurt sales
COVID-19 vaccine recommendations dropped by panel, shots won’t require a prescription
Social Security is on track to be insolvent in less than 10 years — but its commissioner says there’s ‘plenty of time’ to find a solution
Insomnia keeping you up at night? It may also raise your risk for dementia and cognitive impairment.
Micron’s hot streak is ending, but here’s what matters next for the stock
Can Lululemon get new life from the Amex Platinum card? Don’t count on it, analysts say.
Taylor Swift tries to save the movie industry again with ‘Showgirl’ film release
Microsoft’s stock has been in a rut since earnings. What’s going on?
How Nexstar became the tip of the spear in a free-speech fight over Jimmy Kimmel
This is why you can never predict the direction of interest rates
Meta’s new AI glasses impressed investors — but 3 things stop them from going mainstream
Stocks tend to suffer in the second half of September — but the Fed’s rate cut might keep bears at bay
People are complaining that Apple’s new iPhone 17 scratches easily — but these Wall Street analysts say it won’t hurt sales
COVID-19 vaccine recommendations dropped by panel, shots won’t require a prescription
Social Security is on track to be insolvent in less than 10 years — but its commissioner says there’s ‘plenty of time’ to find a solution
Insomnia keeping you up at night? It may also raise your risk for dementia and cognitive impairment.
Micron’s hot streak is ending, but here’s what matters next for the stock
Can Lululemon get new life from the Amex Platinum card? Don’t count on it, analysts say.
Taylor Swift tries to save the movie industry again with ‘Showgirl’ film release
Microsoft’s stock has been in a rut since earnings. What’s going on?
How Nexstar became the tip of the spear in a free-speech fight over Jimmy Kimmel
This is why you can never predict the direction of interest rates
Meta’s new AI glasses impressed investors — but 3 things stop them from going mainstream
Stocks tend to suffer in the second half of September — but the Fed’s rate cut might keep bears at bay
19-09-25
History suggests it could be a downhill ride for stocks through the end of September.
Share this on:
